Anika Therapeutics, Inc.

US$14.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ANIKHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (10.53%)
Div yield —
ROE (0.18%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM —
TSR TTM 49.23%
Mkt cap US$194.9M
ROIC (0.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
4.99%
(19.35%)
Hold 6|11|7|4|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.33
0.37
0.35
0.39
19.43%
34.69%
25.39%
23.55%
Revenue$M
17.71
18.15
17.98
18.20
3.02%
2.54%
2.24%
1.98%
Peers (US$194.9M)
Cap (US$)
PE
194.9M
40.75x
Capital
TTM
5Y
10Y
Leveragex
0.583
1.154
0.978
EBIT/Intx
0.372
0.573
0.381
Own earn%
(36.55)
270.35
250.62
Sh yield%
21.88
53.07
49.21
Owners
Insiders/Inst%
5.98
43.07
Short interest%
4.78
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
21–27
$1 testx
—
Incr. ROIC%
3